Loading clinical trials...
Loading clinical trials...
Multicenter Evaluation of SARS-CoV-2 Vaccines in Patients With CLL/SLL
Conditions
Interventions
Biospecimen Collection
Electronic Health Record Review
Locations
11
United States
City of Hope
Duarte, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Start Date
March 18, 2021
Primary Completion Date
January 1, 2023
Completion Date
July 1, 2024
Last Updated
August 2, 2024
NCT06846671
NCT07218341
NCT07030400
NCT07277231
NCT05006716
NCT06859424
Lead Sponsor
University of Washington
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions